Stay updated on Batoclimab in Myasthenia Gravis: Clinical Trial

Sign up to get notified when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Batoclimab in Myasthenia Gravis: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating an updated page revision.
    Difference
    0.0%
    Check dated 2026-08-10T12:47:45.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page underwent a minor version bump from v3.6.3 to v3.6.4, indicating an update to the ClinicalTrials.gov page, likely a small fix or enhancement that does not change the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:26:51.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision number was updated from v3.6.2 to v3.6.3, indicating a new version of the study details page. This appears to be a minor metadata update rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-05T14:34:36.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page, indicating a newer software iteration of the study details display.
    Difference
    0.0%
    Check dated 2026-06-28T08:36:47.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status on the page has been clarified to indicate no longer looking for participants, aligning with the overall active-not-recruiting state. New help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the revision tag was updated to v3.6.0, while a formatting adjustment standardizes the Intervention/Treatment header.
    Difference
    0.2%
    Check dated 2026-06-13T17:40:27.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Introduces a new secondary outcome: Change from Baseline in MG-ADL score in AChRAb negative participants, expanding analysis to this subgroup. Removes detailed safety endpoints (laboratory parameters, vital signs, and related definitions) from the safety reporting to simplify the section.
    Difference
    0.5%
    Check dated 2026-06-06T13:35:28.000Z thumbnail image

Stay in the know with updates to Batoclimab in Myasthenia Gravis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.